drugset / Trial / NCT07289464
A Clinical Study of RSS0343 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a phase I study to evaluate the safety, tolerability and pharmacokinetics of RSS0343 following multiple oral doses in healthy subjects, as well as its effects on the QT/QTc interval.
Timeline
- Start
- 2026-01-04
- Primary completion
- 2026-09
- Completion
- 2026-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RSS0343 | Unknown | — | Oral |